Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash

Vertex Pharmaceuticals (NASDAQ: VRTX) hasn't made the headlines in recent times like companies involved in high-growth areas such as weight loss drugs or artificial intelligence (AI). But this biotech player has proven its ability over time to develop successful drugs, generate earnings growth, and continue to innovate.Vertex is the global leader in cystic fibrosis (CF) treatment and over the past couple of years branched out into other areas by winning approval for a gene editing treatment for blood disorders and a drug for pain management. All of this should sustain earnings growth during any economic backdrop -- and that's why I would hold this quiet biotech compounder through any market crash.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool